Thomas Jefferson University announced it will head a federal hub program aimed at expanding sickle cell disease care across Pennsylvania. The effort is directed at the state’s nearly 4,000 patients with the condition.
The initiative is designed to increase access to the specialist treatment that sickle cell patients require, which is typically delivered at designated high‑level centers.
Sickle cell disease affects thousands in Pennsylvania and often needs specialized care; the new hub seeks to improve the availability of that care.